GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oneness Biotech Co Ltd (LUX:ONEA) » Definitions » Earnings per Share (Diluted)

Oneness Biotech Co (LUX:ONEA) Earnings per Share (Diluted) : $-0.23 (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Oneness Biotech Co Earnings per Share (Diluted)?

Oneness Biotech Co's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $-0.03. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.23.

Oneness Biotech Co's EPS (Basic) for the three months ended in Mar. 2024 was $-0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.23.

Oneness Biotech Co's EPS without NRI for the three months ended in Mar. 2024 was $-0.03. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.23.

During the past 12 months, Oneness Biotech Co's average EPS without NRIGrowth Rate was -356.60% per year.

During the past 13 years, Oneness Biotech Co's highest 3-Year average EPS without NRI Growth Rate was 117.00% per year. The lowest was -163.80% per year. And the median was -9.80% per year.


Oneness Biotech Co Earnings per Share (Diluted) Historical Data

The historical data trend for Oneness Biotech Co's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oneness Biotech Co Earnings per Share (Diluted) Chart

Oneness Biotech Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.17 -0.19 -0.11 -0.17 0.13

Oneness Biotech Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.24 -0.10 -0.12 -0.08 -0.03

Competitive Comparison of Oneness Biotech Co's Earnings per Share (Diluted)

For the Biotechnology subindustry, Oneness Biotech Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oneness Biotech Co's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oneness Biotech Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Oneness Biotech Co's PE Ratio falls into.



Oneness Biotech Co Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Oneness Biotech Co's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2022 is calculated as

Diluted Earnings Per Share (A: Dec. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(11.744-0)/89.962
=0.13

Oneness Biotech Co's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (Q: Mar. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-2.922-0)/90.990
=-0.03

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Oneness Biotech Co  (LUX:ONEA) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Oneness Biotech Co Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Oneness Biotech Co's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Oneness Biotech Co (LUX:ONEA) Business Description

Traded in Other Exchanges
Address
No. 236, Section 4, Xinyi Road, 11th Floor, Daan District, Taipei, TWN, 106
Oneness Biotech Co Ltd is a Taiwan based biopharmaceutical company. The company develops healthcare drugs. Its products are used for chronic diabetic, dengue hemorrhagic fever, and Rheumatoid Arthritis. The company's operating segment includes New Drug Research and Development and Agricultural Products Cultivation. It generates maximum revenue from New Drug Research and Development segment.

Oneness Biotech Co (LUX:ONEA) Headlines

No Headlines